Cancer Dx Firm Metamark Genetics Raises $22M

The company plans to raise a total of about $42 million for the round, it said in an SEC filing.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories